Dolamind Pharmaceutical Private Limited
About Dolamind Pharmaceutical Private Limited
Data last updated:
Dolamind Pharmaceutical Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the designer and branded fashion segment of the fashion and textiles sector. It was incorporated on 28 November 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2016PTC287972. Its GSTIN is 27AAFCD9319R1ZV (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anil Kumar Shukla and Manish Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Room No. 2 Shri Bal Gopal Sangh Gandhinagar Kurar Village Malad East Cutting No 10, Mumbai, Maharashtra, India – 400097.
As per the financials filed for FY 2025, the company reported a revenue of ₹48.9 Lakh, a growth of 69% compared to the previous year. For the same year it recorded a net profit of ₹1.55 Lakh (net margin 3.2%) and EBITDA of ₹1.61 Lakh (EBITDA margin 3.3%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 16% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressRoom No. 2 Shri Bal Gopal Sangh Gandhinagar Kurar Village Malad East Cutting No 10, Mumbai, Maharashtra, India – 400097
- IndustryFashion and Textile, Designer & Branded Fashion
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Dolamind Pharmaceutical Private Limited
The main business activity of Dolamind Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Dolamind Pharmaceutical Private Limited FY 2025 filings available
Dolamind Pharmaceutical Private Limited reported revenue of ₹48.9 Lakh (up 69% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Dolamind Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 69% growth in the latest year. EBITDA rose 215% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dolamind Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.61 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.55 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dolamind Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dolamind Pharmaceutical are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Dolamind Pharmaceutical Private Limited
Dolamind Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Apparel industry (Branded Wear, Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anzel Advance Care Private Limited | ₹49.1 Lakh (FY 2020) | •••• | •••• | 27.0% | •••• | Kolkata, West Bengal, India |
| Sandee Medicare Private Limited | ₹49.04 Lakh (FY 2024) | •••• | •••• | -19.0% | •••• | Delhi, India |
| Unisoul Lifescience Private Limited | ₹48.93 Lakh (FY 2024) | •••• | •••• | 83.0% | •••• | Nagpur, Maharashtra, India |
| D.S.Aiyyelu Dance Costume Designer Private Limited | ₹48.9 Lakh (FY 2025) | •••• | •••• | 86.0% | •••• | Chennai, Tamil Nadu, India |
| Zedon Biotech Private Limited | ₹48.9 Lakh (FY 2024) | •••• | •••• | 5.0% | •••• | Mumbai, Maharashtra, India |
| Dolamind Pharmaceutical Private Limited this company | ₹48.9 Lakh (FY 2025) | •••• | •••• | 69.0% | •••• | Mumbai, Maharashtra, India |
| Amitav Health Care Centre Private Limited | ₹48.9 Lakh (FY 2024) | •••• | •••• | 64.0% | •••• | Tal Jath, Dist Sangli, Maharashtra, India |
| Meddroid Pharmaceutical Private Limited | ₹48.84 Lakh (FY 2025) | •••• | •••• | 76.0% | •••• | New Delhi, Delhi, India |
| Styrax Healthcare Private Limited | ₹48.84 Lakh (FY 2024) | •••• | •••• | -21.0% | •••• | Amritsar, Punjab, India |
| Coxswain Bio Remedies Private Limited | ₹48.81 Lakh (FY 2024) | •••• | •••• | -21.0% | •••• | Hisar, Haryana, India |
| Inventive Impex Private Limited | ₹48.8 Lakh (FY 2025) | •••• | •••• | 307.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Dolamind Pharmaceutical by revenue in the Apparel industry (Branded Wear, Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Dolamind Pharmaceutical Private Limited
Dolamind Pharmaceutical Private Limited is audited by ANKIT D DHAROD AND CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ANKIT D DHAROD AND CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Dolamind Pharmaceutical Private Limited
Dolamind Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Shukla | Director | 28 Nov 2016 | 9 Years 10 Months | Current |
| Manish Kumar | Director | 28 Nov 2016 | 9 Years 10 Months | Current |
Ownership and Shareholding of Dolamind Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dolamind Pharmaceutical Private Limited
Dolamind Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Dolamind Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Dolamind Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Dolamind Pharmaceutical Private Limited
Dolamind Pharmaceutical Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Anil Kumar Shukla was appointed as Director on 28 Nov 2016.
Credit Ratings, Litigation & Regulatory Alerts for Dolamind Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dolamind Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dolamind Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dolamind Pharmaceutical Private Limited
Dolamind Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCD9319R1ZV | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dolamind Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dolamind Pharmaceutical Private Limited
Dolamind Pharmaceutical is an active private limited company based in Mumbai, Maharashtra, India. The company works in designer and branded fashion, within the fashion and textile industry. It was incorporated on 28 November 2016 (10+ years old) and is registered under CIN U74999MH2016PTC287972.
Dolamind Pharmaceutical reported revenue of ₹48.9 Lakh for FY 2025 (up 69% YoY).
Dolamind Pharmaceutical has 2 current directors:
- Anil Kumar Shukla - Director
- Manish Kumar - Director
Dolamind Pharmaceutical reported a net profit of ₹1.55 Lakh (net margin 3.2%) and EBITDA of ₹1.61 Lakh (EBITDA margin 3.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Dolamind Pharmaceutical is 28% over three years and 16% over five years. In the latest year (FY 2025) revenue rose 69%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Dolamind Pharmaceutical is 27AAFCD9319R1ZV, registered in Maharashtra.
The CIN (Corporate Identification Number) of Dolamind Pharmaceutical is U74999MH2016PTC287972. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dolamind Pharmaceutical was incorporated on 28 November 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Dolamind Pharmaceutical by revenue are Anzel Advance Care Private Limited, Sandee Medicare Private Limited, Unisoul Lifescience Private Limited, D.S.Aiyyelu Dance Costume Designer Private Limited, Zedon Biotech Private Limited and 5 more, all in the Apparel industry (Branded Wear, Pharma Retail and Distribution).
Anil Kumar Shukla was appointed as Director on 28 Nov 2016. Manish Kumar was appointed as Director on 28 Nov 2016.
The registered office of Dolamind Pharmaceutical is at Room No. 2 Shri Bal Gopal Sangh Gandhinagar Kurar Village Malad East Cutting No 10, Mumbai, Maharashtra, India – 400097.